Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: A prospective, randomized trial

American Journal of Medicine

Volumn 116, Issue 4, 2004, Pages 230-235

  Aljabri, Khaled ^a   Kozak, Sharon E ^a   Thompson, David M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPOGLYCEMIA; LEG EDEMA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URINE LEVEL;

EID: 1242283924     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.07.023     Document Type: Article

References (31)

1. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
2. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus a randomized, prospective 6-year study . Diabetes Res Clin Pract. 28:1995;103-117.
3. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 25:(suppl 1):2002;S33-S49.
4. Turner R.C., Cull A., Frighi V., Holman R.R. Glycemic control with diet, sulphonylurea, metformin or insulin in patients with type 2 diabetes. Progressive requirement for multiple therapies (UKPDS 49). JAMA. 281:1999;2005-2012.
5. Harris M.I. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care. 23:2000;734-738.
6. Hayward R.A., Manning W.G., Kaplan S.H., et al. Starting insulin therapy in patients with type 2 diabetes. Effectiveness, complications and resource utilization. JAMA. 278:1997;1663-1669.
7. Day C. Thiazolidenediones a new class of antidiabetic drugs . Diabet Med. 16:1999;179-192.
8. Yale J., Valiquett T., Ghazzi M., et al. The effect of a thiazolidenedione drug, troglitazone, on glycemia in patients with type 2 diabetes poorly controlled with sulphonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial. Troglitazone triple-therapy study group. Ann Intern Med. 134:2001;737-745.
9. Kiayias J., Vlachou E., Theodosopoulou E., Lakka-Papadodima E. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients. Diabetes Care. 25:2002;1251-1252.
10. Cryer P., Fisher J., Shamoon H. Hypoglycemia. Diabetes Care. 17:1994;734-755.
11. Bradley C., Gamsu D.S. Guidelines for encouraging psychological well-being. Report of a working group of the World Health Organization and International Diabetes Federation European Region St. Vincent Declaration action programme for diabetes. Diabet Med. 11:1994;510-516.
12. Greenfield S., Rogers W., Mangotich M., et al. Outcomes of patients with hypertension and non-insulin-dependent diabetes mellitus treated by different systems and specialties. JAMA. 274:1995;1436-1444.
13. Turner R.C. The UK Prospective Diabetes Study a review . Diabetes Care. 21:(suppl 3):1998;C35-C38.
14. Harris M.I. Medical care for patients with diabetes. Epidemiologic aspects. Ann Intern Med. 124:1996;117-122.
15. Larme A.C., Pugh J.A. Attitudes of primary care providers toward diabetes. Barriers to guideline implementation. Diabetes Care. 23:1998;1391-1396.
16. Nathan D.M. Treating type 2 diabetes with respect. Ann Intern Med. 130:1998;440-441.
17. Harris M.I. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care. 23:2000;734-738.
18. Gray A., Raikon M., McGuire A., et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes economic analysis alongside randomized controlled trial (UKPDS 41) . BMJ. 320:2000;1373-1378.
19. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS35) prospective observational study . BMJ. 321:2000;405-412.
20. Aronoff S., Rosenblatt S., Braithwaite S., et al. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes a 6-month randomized placebo-controlled dose-response study . Diabetes Care. 23:2000;1605-1611.
21. Yki-Jarvinen H., Kauppila M., Kujansuu E., et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 327:1992;426-433.
22. Chow C.-C., Tsang L., Sorensen J.P., Cockram C.S. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes Care. 18:1995;307-314.
23. Yki-Jarvinen H., Ryysy L., Nikkila K., et al. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Intern Med. 130:1999;389-396.
24. Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care. 24:2001;758-767.
25. Abraira C., Colwell J.A., Nuttall F.Q., et al. Veterans Affairs Cooperative Study on glycemic control and complications in Type II diabetes (VACSDM) results of the feasibility trial . Diabetes Care. 18:1995;1113-1123.
26. Thompson D.M., Kozak S.E., Sheps S. Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients a randomized trial . CMAJ. 161:1999;959-962.
27. DeFronzo R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 131:1999;281-303.
28. Yale J.-F., Begg I., Gerstein H., et al. 2001 Canadian Diabetes Association clinical practice guidelines for the prevention and management of hypoglycemia in diabetes. Can J Diabetes. 26:2002;22-35.
29. Gu K., Cowie C.C., Harris M.I. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 21:1998;1138-1145.
30. Kipnes M.S., Krosnick A., Rendell M.S., et al. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus a randomized, placebo-controlled study . Am J Med. 111:2001;10-17.
31. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care. 22:1999;1125-1136.